...
首页> 外文期刊>Toxicology and Applied Pharmacology >Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.
【24h】

Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.

机译:微粒体酶诱导剂对各种大鼠组织中外环脱碘酶对甲状腺激素的活性的影响。

获取原文
获取原文并翻译 | 示例

摘要

Microsomal enzyme inducers, such as phenobarbital (PB), pregnenolone-16alpha-carbonitrile (PCN), 3-methylcholanthrene (3MC), and Aroclor 1254 (PCB) are more effective at reducing serum thyroxine (T(4)) than serum triiodothyronine (T(3)). It is possible that rats treated with PB and PCN maintain serum T(3) by increasing serum TSH, which stimulates the thyroid gland to synthesize more T(3). However, it is unclear how serum T(3) is maintained in rats treated with 3MC or PCB, because serum TSH is not increased in these rats. We hypothesized that increased conversion of T(4) to T(3), catalyzed by outer-ring deiodinases (ORD) type-I and -II, is the reason serum T(3) is maintained in rats treated with 3MC or PCB. Furthermore, 3MC and PCB do not increase serum TSH, whereas PB and PCN do, because type-II ORD activity in the pituitary of 3MC- and PCB-treated rats is increased greater than in rats treated with PB or PCN. To test these two hypotheses, male Sprague-Dawley rats were fed either a basal diet or a diet containing PB (300, 600, 1200, or 2400 ppm), PCN (200, 400, 800, or 1600 ppm), 3MC (50, 100, 200, or 400 ppm), or PCB (25, 50, 100, or 200 ppm) for 7 days. Type-I ORD activity was measured in thyroid, kidney, and liver, whereas type-II ORD activity was measured in brown adipose tissue, pituitary, and brain. Type-I ORD activity in thyroid was not affected by PB, 3MC, or PCB treatments, and was slightly increased by PCN. Type-I ORD activity in kidney was not affected by PB, PCN, or 3MC treatments, and was reduced by PCB treatment. Type-I ORD activity in liver was reduced by PB, PCN, 3MC, and PCB treatments. Type-II ORD activity in brown adipose tissue was unaffected by any of the four treatments. Type-II ORD activity in pituitary was unaffected by PB or 3MC treatments, and was increased by PCN or PCB treatments. Type-II ORD activity in brain was unaffected by PB treatment, and was increased by PCN, 3MC, and PCB treatments. Overall, total ORD activity, calculated by summation of ORD activities in thyroid, kidney, liver, brown adipose tissue, pituitary, and brain, was reduced rather than increased by the four microsomal enzyme inducers. In conclusion, increased conversion of T(4) to T(3) is not the reason serum T(3) concentration is maintained in 3MC- or PCB-treated rats. Furthermore, the reason serum TSH is not increased in 3MC- and PCB-treated rats is the result of mechanisms other than increased type-II ORD activity in pituitary. Copyright 2000 Academic Press.
机译:微粒体酶诱导剂,例如苯巴比妥(PB),孕烯醇酮-16α-腈(PCN),3-甲基胆碱(3MC)和Aroclor 1254(PCB)在降低血清甲状腺素(T(4))方面比降低血清三碘甲状腺素( T(3))。用PB和PCN处理的大鼠有可能通过增加血清TSH来维持血清T(3),从而刺激甲状腺合成更多的T(3)。但是,尚不清楚在用3MC或PCB处理的大鼠中如何维持血清T(3),因为这些大鼠中的血清TSH并未增加。我们假设外环脱碘酶(ORD)-I和-II催化T(4)向T(3)的转化增加,是在用3MC或PCB处理的大鼠中维持血清T(3)的原因。此外,3MC和PCB不会增加血清TSH,而PB和PCN会增加,因为3MC和PCB处理的大鼠垂体中的II型ORD活性比用PB或PCN处理的大鼠更高。为了检验这两个假设,对雄性Sprague-Dawley大鼠进行基础饮食或含PB(300、600、1200或2400 ppm),PCN(200、400、800或1600 ppm),3MC(50 ,100、200或400 ppm)或PCB(25、50、100或200 ppm)放置7天。在甲状腺,肾脏和肝脏中测量了I型ORD活性,而在棕色脂肪组织,垂体和脑中测量了II型ORD活性。 PB,3MC或PCB处理不影响甲状腺的I型ORD活性,而PCN则略有增加。 PB,PCN或3MC治疗不影响肾脏的I型ORD活性,而PCB治疗则降低了I型ORD活性。 PB,PCN,3MC和PCB处理可降低肝脏的I型ORD活性。两种处理方法均不影响棕色脂肪组织中的II型ORD活性。垂体的II型ORD活性不受PB或3MC处理的影响,而受PCN或PCB处理的影响增加。 PB治疗不会影响大脑中的II型ORD活性,而PCN,3MC和PCB治疗会增加II型ORD活性。总体而言,四种甲状腺酶诱导剂可降低总ORD活性,而不是通过增加甲状腺,肾脏,肝脏,褐色脂肪组织,垂体和脑中ORD活性来计算。总之,T(4)到T(3)的增加转化并不是在3MC或PCB处理的大鼠中维持血清T(3)浓度的原因。此外,在3MC和PCB处理的大鼠中血清TSH不增加的原因是除垂体II型ORD活性增加以外的其他机制的结果。版权所有2000学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号